DK0778025T3 - Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler - Google Patents

Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler

Info

Publication number
DK0778025T3
DK0778025T3 DK96308632T DK96308632T DK0778025T3 DK 0778025 T3 DK0778025 T3 DK 0778025T3 DK 96308632 T DK96308632 T DK 96308632T DK 96308632 T DK96308632 T DK 96308632T DK 0778025 T3 DK0778025 T3 DK 0778025T3
Authority
DK
Denmark
Prior art keywords
dehydroestrone
drug
manufacture
treatment
free radicals
Prior art date
Application number
DK96308632T
Other languages
Danish (da)
English (en)
Inventor
Steven Jay Adelman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0778025T3 publication Critical patent/DK0778025T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK96308632T 1995-12-04 1996-11-28 Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler DK0778025T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US793195P 1995-12-04 1995-12-04

Publications (1)

Publication Number Publication Date
DK0778025T3 true DK0778025T3 (da) 2004-06-07

Family

ID=21728885

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96308632T DK0778025T3 (da) 1995-12-04 1996-11-28 Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler

Country Status (23)

Country Link
EP (1) EP0778025B1 (de)
JP (1) JPH09169650A (de)
KR (1) KR100444002B1 (de)
CN (1) CN1104900C (de)
AR (2) AR005866A1 (de)
AT (1) ATE263565T1 (de)
AU (1) AU703814B2 (de)
BR (1) BR9605777A (de)
CA (1) CA2191835A1 (de)
CZ (1) CZ289780B6 (de)
DE (1) DE69632117T2 (de)
DK (1) DK0778025T3 (de)
ES (1) ES2215187T3 (de)
HK (1) HK1010095A1 (de)
HU (1) HUP9603329A3 (de)
IL (1) IL119744A (de)
MX (1) MX9606009A (de)
NO (1) NO312654B1 (de)
NZ (1) NZ299858A (de)
PT (1) PT778025E (de)
SI (1) SI0778025T1 (de)
SK (1) SK154296A3 (de)
ZA (1) ZA969923B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US7892751B2 (en) 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
AU2004248155B2 (en) * 2003-06-09 2008-10-23 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene

Also Published As

Publication number Publication date
HUP9603329A2 (en) 1997-08-28
CN1158725A (zh) 1997-09-10
ZA969923B (en) 1998-05-26
HU9603329D0 (en) 1997-01-28
SK154296A3 (en) 1997-08-06
DE69632117T2 (de) 2004-08-26
HK1010095A1 (en) 1999-06-11
EP0778025A1 (de) 1997-06-11
EP0778025B1 (de) 2004-04-07
CA2191835A1 (en) 1997-06-05
NO965165L (no) 1997-06-05
IL119744A0 (en) 1997-03-18
MX9606009A (es) 1997-08-30
CN1104900C (zh) 2003-04-09
NO312654B1 (no) 2002-06-17
AU703814B2 (en) 1999-04-01
AU7194496A (en) 1997-06-12
CZ353296A3 (en) 1997-08-13
CZ289780B6 (cs) 2002-04-17
IL119744A (en) 2003-01-12
JPH09169650A (ja) 1997-06-30
KR100444002B1 (ko) 2004-11-03
NO965165D0 (no) 1996-12-03
DE69632117D1 (de) 2004-05-13
AR005866A1 (es) 1999-07-21
KR970032870A (ko) 1997-07-22
ATE263565T1 (de) 2004-04-15
NZ299858A (en) 2001-03-30
AR059965A2 (es) 2008-05-14
PT778025E (pt) 2004-08-31
ES2215187T3 (es) 2004-10-01
HUP9603329A3 (en) 1998-01-28
SI0778025T1 (en) 2004-08-31
BR9605777A (pt) 1998-08-25

Similar Documents

Publication Publication Date Title
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
FI20105844A (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK0769947T3 (da) Indolinonforbindelser til behandling af sygdom
DE69105829D1 (de) Nasenmaske.
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
DK19893A (da) Praeparat til nasal behandling
DK0859615T3 (da) Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
DK0467564T3 (da) Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
DK0778025T3 (da) Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler
DE69618560T2 (de) Medikament gegen ophthalmische erkrankungen
DK0874843T3 (da) Substituerede 4-(1H-benzimidazol-2-yl)(1,4)diazepaner, der er nyttige til behandling af allergisygdomme
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
DK101197A (da) Medikament til behandling af thrombocytopenia
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
DK0671910T3 (da) Anvendelse af adamantanderivater til fremstilling af et lægemiddel til behandling af glaucoma